News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
666,104 Results
Type
Article (62400)
Company Profile (77)
Press Release (603618)
Multimedia
Podcasts (102)
Webinars (21)
Section
Business (174038)
Career Advice (2749)
Deals (32517)
Drug Delivery (116)
Drug Development (77094)
Employer Resources (154)
FDA (15157)
Job Trends (13946)
News (305769)
Policy (29118)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (2)
Academia (2909)
Academic (2)
Accelerated approval (33)
Adcomms (28)
Allergies (142)
Alliances (43256)
ALS (167)
Alzheimer's disease (1599)
Antibody-drug conjugate (ADC) (290)
Approvals (15430)
Artificial intelligence (528)
Autoimmune disease (160)
Automation (37)
Bankruptcy (291)
Best Places to Work (10853)
BIOSECURE Act (16)
Biosimilars (176)
Biotechnology (55)
Bladder cancer (154)
Brain cancer (60)
Breast cancer (625)
Cancer (4694)
Cardiovascular disease (392)
Career advice (2347)
Career pathing (40)
CAR-T (288)
CDC (45)
Celiac Disease (2)
Cell therapy (763)
Cervical cancer (35)
Clinical research (66010)
Collaboration (1647)
Company closure (5)
Compensation (712)
Complete response letters (56)
COVID-19 (2683)
CRISPR (92)
C-suite (900)
Cystic fibrosis (144)
Data (6103)
Decentralized trials (2)
Denatured (41)
Depression (132)
Diabetes (470)
Diagnostics (6467)
Digital health (45)
Diversity (13)
Diversity, equity & inclusion (40)
Drug discovery (244)
Drug pricing (185)
Drug shortages (25)
Duchenne muscular dystrophy (212)
Earnings (63238)
Editorial (59)
Employer branding (18)
Employer resources (138)
Events (98592)
Executive appointments (1032)
FDA (18253)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (23)
Funding (1457)
Gene editing (200)
Generative AI (44)
Gene therapy (572)
GLP-1 (909)
Government (4705)
Grass and pollen (7)
Guidances (380)
Healthcare (18258)
HIV (56)
Huntington's disease (39)
IgA nephropathy (79)
Immunology and inflammation (223)
Immuno-oncology (53)
Indications (103)
Infectious disease (2938)
Inflammatory bowel disease (186)
Inflation Reduction Act (13)
Influenza (115)
Intellectual property (245)
Interviews (530)
IPO (14907)
IRA (45)
Job creations (3419)
Job search strategy (1947)
JPM (62)
Kidney cancer (17)
Labor market (75)
Layoffs (591)
Leadership (36)
Legal (6471)
Liver cancer (84)
Longevity (12)
Lung cancer (621)
Lymphoma (362)
Machine learning (40)
Management (54)
Manufacturing (742)
MASH (163)
Medical device (13036)
Medtech (13085)
Mergers & acquisitions (18724)
Metabolic disorders (1204)
Multiple sclerosis (150)
NASH (13)
Neurodegenerative disease (302)
Neuropsychiatric disorders (86)
Neuroscience (2783)
Neurotech (1)
NextGen: Class of 2026 (6384)
Non-profit (4349)
Now hiring (21)
Obesity (548)
Opinion (290)
Ovarian cancer (161)
Pain (199)
Pancreatic cancer (223)
Parkinson's disease (273)
Partnered (33)
Patents (494)
Patient recruitment (506)
Peanut (58)
People (61206)
Pharmaceutical (19)
Pharmacy benefit managers (26)
Phase 1 (20806)
Phase 2 (29100)
Phase 3 (21243)
Pipeline (5097)
Policy (271)
Postmarket research (2470)
Preclinical (8840)
Press Release (67)
Prostate cancer (241)
Psychedelics (41)
Radiopharmaceuticals (279)
Rare diseases (817)
Real estate (6033)
Recruiting (66)
Regulatory (22267)
Reports (40)
Research institute (2463)
Resumes & cover letters (408)
Rett syndrome (28)
RNA editing (15)
RSV (66)
Schizophrenia (143)
Series A (240)
Series B (184)
Service/supplier (8)
Sickle cell disease (93)
Special edition (15)
Spinal muscular atrophy (155)
Sponsored (43)
Startups (3378)
State (1)
Stomach cancer (11)
Supply chain (86)
Tariffs (67)
The Weekly (59)
Vaccines (970)
Venture capital (77)
Weight loss (336)
Women's health (81)
Worklife (21)
Date
Today (135)
Last 7 days (547)
Last 30 days (1995)
Last 365 days (28401)
2026 (3229)
2025 (28673)
2024 (32268)
2023 (36328)
2022 (46608)
2021 (51559)
2020 (50709)
2019 (44759)
2018 (34050)
2017 (30711)
2016 (30054)
2015 (35429)
2014 (28372)
2013 (24948)
2012 (26210)
2011 (26449)
2010 (24921)
Location
Africa (886)
Alabama (84)
Alaska (6)
Arizona (238)
Arkansas (14)
Asia (39392)
Australia (7067)
California (10323)
Canada (3046)
China (1053)
Colorado (438)
Connecticut (441)
Delaware (325)
Europe (91833)
Florida (1553)
Georgia (344)
Hawaii (3)
Idaho (59)
Illinois (868)
India (65)
Indiana (473)
Iowa (22)
Japan (409)
Kansas (118)
Kentucky (39)
Louisiana (26)
Maine (74)
Maryland (1271)
Massachusetts (7281)
Michigan (332)
Minnesota (561)
Mississippi (6)
Missouri (137)
Montana (34)
Nebraska (26)
Nevada (113)
New Hampshire (76)
New Jersey (2869)
New Mexico (30)
New York (2812)
North Carolina (1402)
North Dakota (10)
Northern California (4980)
Ohio (317)
Oklahoma (23)
Oregon (42)
Pennsylvania (2038)
Puerto Rico (24)
Rhode Island (44)
South America (1187)
South Carolina (52)
South Dakota (1)
Southern California (4101)
Tennessee (167)
Texas (1649)
United States (37034)
Utah (319)
Vermont (1)
Virginia (256)
Washington D.C. (66)
Washington State (853)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
666,104 Results for "university of antwerp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
ElmediX Plans Series A Round Based on Strong Signals in a Clinical Study for Pancreatic Cancer Patients at the University Hospital Antwerp (Belgium)
Earlier this year, scientists from Columbia University in New York demonstrated that the growth rate of pancreatic cancer, measured in patients’ blood using CA19-9 as biomarker, determines survival chances and can be used as a quick way to assess treatment effectiveness.
June 14, 2024
·
3 min read
Press Releases
First-of-its-kind Universal Clearance Establishes Maximum Regulatory Access to the Bezier Parametric Curve Spinal Rod System for Patients and Surgeons
February 5, 2026
·
2 min read
Press Releases
Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds: Highlights Strong Safety, Functional Gains, and Florida Access Pathway
Session led by neurosurgeon Dr. Fraser Henderson and Hemostemix CEO Thomas Smeenk for the University of Florida’s Department of Surgery, Division of Vascular Surgery & Endovascular Therapy (Gainesville)
November 13, 2025
·
10 min read
Press Releases
Agomab Announces Closing of Initial Public Offering
February 10, 2026
·
4 min read
Press Releases
Agomab Announces Launch of Initial Public Offering
February 2, 2026
·
4 min read
Press Releases
Agomab Announces Pricing of Initial Public Offering
February 6, 2026
·
4 min read
Press Releases
University of Phoenix appoints Sheila Babendir as Dean of the College of Social and Behavioral Sciences
January 21, 2026
·
3 min read
Press Releases
Charles River Enters Manufacturing Collaboration with Gazi University
January 21, 2026
·
2 min read
Press Releases
University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund
January 12, 2026
·
6 min read
Press Releases
Centivax Initiates Phase 1 First-in-Human Clinical Trial of Universal Flu Vaccine
February 12, 2026
·
5 min read
1 of 66,611
Next
